Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

PSA increases turnaround times due to high demand

PSA is increasing turnaround times for grading and authentication services due to high demand, the company announced Thursday. The grader is also changing when estimated turnaround times begin, with ...

John Tesh Talks Of Battling Prostate Cancer That Doesn’t Produce PSA

John Tesh was diagnosed with prostate cancer despite having a low PSA and given 18 months to live back in 2015. Now, 10 years ...
Targeted Oncology

FDA Approves Novel Blood-Based Assay to Stratify Prostate Cancer Biopsy Risk

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...
MedPage Today on MSN

FDA OKs Blood-Based Test to Help Detect High-Grade Prostate Tumors

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.
News Medical

What Should You Avoid Before a PSA Test?

A Prostate-Specific Antigen (PSA) test is a procedure formed on men to detect prostate cancer. It is considered an effective means of cancer screening and can be used to monitor the effectiveness of ...

The PSA aired just days before the House is set to vote on a bill to release all records related to the convicted child sex offender.

Survivors of Jeffrey Epstein’s abuse are demanding Congress release all files related to the convicted sex offender in a new ...